drugset / Trial / NCT00004032
Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase I trial to study the effectiveness of a tumor cell vaccine and interferon gamma in patients with refractory epithelial ovarian cancer. Vaccines made from a person's cancer cells may make the body build an immune response to and kill their tumor cells. Combining vaccine therapy with interferon gamma may be a more effective treatment for epithelial ovarian cancer
Timeline
- Start
- 1997-10
- Primary completion
- 2004-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALVAC-hB7.1 | Unknown | — | Other |
| Subject | interferon gamma | Protein / enzyme biologic | — | Other |